Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). [electronic resource]
Producer: 19961010Description: 229-33 p. digitalISSN:- 0954-691X
- Administration, Oral
- Adolescent
- Adult
- Aged
- Aminosalicylic Acids -- administration & dosage
- Anastomosis, Surgical
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Chemoprevention
- Colonic Diseases -- pathology
- Colonoscopy
- Constriction, Pathologic -- pathology
- Crohn Disease -- pathology
- Double-Blind Method
- Drug Tolerance
- Female
- Humans
- Ileal Diseases -- pathology
- Male
- Mesalamine
- Middle Aged
- Placebos
- Recurrence
- Ulcer -- pathology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.